Single-dose bioavailability for prophylactic coverage in patients undergoing dental implant surgery
The International Journal of Oral & Maxillofacial Implants Mar 22, 2018
Aravena PC, et al. - The aim of authors in this prospective study was to quantify amoxicillin plasma levels in the peripheral venous blood and at the surgical implant site in subjects who underwent dental treatment. They noted higher plasma concentrations in a prophylactic dose of amoxicillin than the minimum inhibitory concentration required to prevent the common dental bacteria involved in peri-implantitis and periodontal diseases.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries